New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer

New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a specific subtype of breast cancer lacking hormone receptor expression and HER2 gene amplification. TNBC represents a heterogeneous subtype of breast cancer, characterized by poor prognosis, high invasiveness, high metastatic potential, and a tendency to rela...

Full description

Bibliographic Details
Main Authors: Brahim El Hejjioui, Salma Lamrabet, Sarah Amrani Joutei, Nadia Senhaji, Touria Bouhafa, Moulay Abdelilah Malhouf, Sanae Bennis, Laila Bouguenouch
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Diagnostics
Subjects:
triple-negative breast cancer (TNBC)
molecular subtype
biomarkers
omics
neoadjuvant treatments
Online Access:https://www.mdpi.com/2075-4418/13/11/1949

Internet

https://www.mdpi.com/2075-4418/13/11/1949

Similar Items